SOCIAL MEDIA WARNING: Alluvi has never operated on any social media platforms. Please don't make any payments or fall victim to anything claiming to be Alluvi on social media platforms. | OFFICIAL SITE: Our official site is www.alluvi.org — we are only handling this site. Please Beware of other scam sites. | RESEARCH USE ONLY – NOT FOR HUMAN CONSUMPTION: All products are for laboratory research and in vitro studies only. Not for human or veterinary use.
SOCIAL MEDIA WARNING: Alluvi has never operated on any social media platforms. Please don't make any payments or fall victim to anything claiming to be Alluvi on social media platforms. | OFFICIAL SITE: Our official site is www.alluvi.org — we are only handling this site. Please Beware of other scam sites. | RESEARCH USE ONLY – NOT FOR HUMAN CONSUMPTION: All products are for laboratory research and in vitro studies only. Not for human or veterinary use.
SOCIAL MEDIA WARNING: Alluvi has never operated on any social media platforms. Please don't make any payments or fall victim to anything claiming to be Alluvi on social media platforms. | OFFICIAL SITE: Our official site is www.alluvi.org — we are only handling this site. Please Beware of other scam sites. | RESEARCH USE ONLY – NOT FOR HUMAN CONSUMPTION: All products are for laboratory research and in vitro studies only. Not for human or veterinary use.
SOCIAL MEDIA WARNING: Alluvi has never operated on any social media platforms. Please don't make any payments or fall victim to anything claiming to be Alluvi on social media platforms. | OFFICIAL SITE: Our official site is www.alluvi.org — we are only handling this site. Please Beware of other scam sites. | RESEARCH USE ONLY – NOT FOR HUMAN CONSUMPTION: All products are for laboratory research and in vitro studies only. Not for human or veterinary use.
£89.84
Tirzepatide is a synthetic, 39-amino-acid polypeptide engineered as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Incorporating a C20 fatty diacid moiety conjugated via a hydrophilic linker, this molecular architecture extends plasma half-life and optimizes binding affinities for metabolic research applications.
Unit Configuration: 20mg Lyophilized Research Vial
Sequence: 39-residue modified peptide chain with C-terminal amide
Molecular Weight: 4813.45 g/mol
CAS Number: 2023788-19-2
As a twincretin agonist, the compound stimulates insulin secretion through complementary pathways while inhibiting glucagon release in a glucose-dependent manner. Analytical laboratories examine its cellular activity across multiple metabolic parameters:
Incretin Synergy: Activates both GIP and GLP-1 receptors simultaneously, showing enhanced intracellular signaling compared to single-agonist models.
Enzymatic Stability: Modified with $\alpha$-aminoisobutyric acid (Aib) residues at positions 2 and 13 to resist dipeptidyl peptidase-4 (DPP-4) enzymatic degradation.
Receptor Kinetics: Evaluates downstream cyclic AMP (cAMP) accumulation and receptor internalization in transfected cell lines.
When acquiring materials through a verified tirzepatide online supplier, academic institutions and analytical laboratories require rigorous high-performance liquid chromatography and mass spectrometry verification to confirm structural integrity.
While public consumer queries sometimes mistake structural formats for oral tirzepatide pills or finished clinical medications like a standard tirzepatide injection, research reagents are strictly distributed as lyophilized chemical standards. Investigators examining a custom tirzepatide compound or seeking a reliable source for tirzepatide for sale must ensure materials are handled strictly for in vitro laboratory experimentation rather than therapeutic use.
Receptor Chemicals provides high-purity research compounds manufactured under strict analytical controls. Each batch undergoes rigorous testing to guarantee absolute molecular consistency and stability across advanced biochemical assays.